RSV - HealthQuill

About Us

Bharti Rana Jayshankar – Founder

She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.

Jay Shankar – Co-founder

He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.

Contact Info

info@healthquill.com

A rise in cases of respiratory infections in China is within the expected range during this time of the year, and the World Health Organization has not observed “unusual outbreak patterns.”

Respiratory infections in China have no ‘unusual outbreak patterns’

A rise in cases of respiratory infections in China is within the expected range during this time of the year, and the World.

by HealthQuill
January 8, 2025
0 Comments

Harvard University researchers have developed a drug-free nasal spray that blocks, and neutralizes viruses and bacteria.

Drugs Health Medical

Harvard develops drug-free nasal spray to block viruses, bacteria

Harvard University researchers have developed a drug-free nasal spray that blocks, and neutralizes viruses and bacteria.

by HealthQuill
October 3, 2024
0 Comments

British pharmaceutical company, GSK Plc’s vaccine against the respiratory syncytial virus has shown positive data on its efficacy to treat older adults during a phase III stage trial.

Drugs Health Pharma

GSK’s RSV vaccine shows positive data on efficacy in older adults

HQ Team June 21, 2023: British pharmaceutical company, GSK Plc’s vaccine against the respiratory syncytial virus has shown positive data on its efficacy.